Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01547286 · ClinicalTrials.gov registry record · NA
Imaging Study of the Lungs During an Allergic Asthma Attack
A NA study of Asthma and Atopy, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT01547286 is a NA study of Asthma and Atopy that has completed, run by Massachusetts General Hospital. The registered enrollment target is 7 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01547286, a NA study of Asthma and Atopy, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
Asthma is a disease of rapidly increasing incidence that already affects more than 17 million people in the United States alone. It has long been known that areas of severely reduced airflow occur in asthma and contribute significantly to the impairment of gas exchange in this disease. However, the extent to which local blood flow changes during an asthmatic attack is unclear. The purpose of this study is using Positron Emission Tomography - Computed Tomography imaging to evaluate how the blood flow changes in the lungs during an asthma attack induced by allergens.
Interventions
- BIOLOGICAL Standardized Cat Allergen Extract and Standardized Dust Mite Allergen
- RADIATION Computed Tomography imaging, functional Positron Emission Tomography imaging
- DRUG Nebulized methacholine inhalation
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01547286
The ClinicalTrials.gov registry entry for NCT01547286 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which Standardized Cat Allergen Extract and Standardized Dust Mite Allergen is the first listed.
NCT01547286 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01547286 about?
NCT01547286 is a clinical study titled "Imaging Study of the Lungs During an Allergic Asthma Attack". Asthma is a disease of rapidly increasing incidence that already affects more than 17 million people in the United States alone. It has long been known that areas of severely reduced airflow occur in asthma and contribute significantly to the impairment of gas exchange in this disease. However, the ...
What is the current status of trial NCT01547286?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2012-05. Estimated completion is 2013-10.
What conditions does trial NCT01547286 study?
This clinical trial studies the following conditions: Asthma, Atopy.
What interventions are being tested in trial NCT01547286?
The interventions under investigation include: Standardized Cat Allergen Extract and Standardized Dust Mite Allergen (BIOLOGICAL), Computed Tomography imaging, functional Positron Emission Tomography imaging (RADIATION), Nebulized methacholine inhalation (DRUG).
Who is sponsoring clinical trial NCT01547286?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01547286 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.